XRTX
Price:
$1.115
Market Cap:
$3.85M
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medi...[Read more]
Industry
Biotechnology
IPO Date
2021-09-23
Stock Exchange
NASDAQ
Ticker
XRTX
According to XORTX Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.61M. This represents a change of 15.12% compared to the average of 1.40M of the last 4 quarters.
The mean historical Enterprise Value of XORTX Therapeutics Inc. over the last ten years is 40.44M. The current 1.61M Enterprise Value has changed 299.23% with respect to the historical average. Over the past ten years (40 quarters), XRTX's Enterprise Value was at its highest in in the March 2022 quarter at 267.93M. The Enterprise Value was at its lowest in in the September 2024 quarter at -2239279.00.
Average
40.44M
Median
7.82M
Minimum
797.98K
Maximum
205.94M
Discovering the peaks and valleys of XORTX Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.74%
Maximum Annual Enterprise Value = 205.94M
Minimum Annual Increase = -99.28%
Minimum Annual Enterprise Value = 797.98K
Year | Enterprise Value | Change |
---|---|---|
2023 | 896.59K | -99.28% |
2022 | 123.93M | -39.82% |
2021 | 205.94M | 1.74% |
2020 | 11.17M | 11.04% |
2019 | 10.06M | 28.65% |
2018 | 7.82M | 404.22% |
2017 | 1.55M | -14.80% |
2016 | 1.82M | 128.14% |
The current Enterprise Value of XORTX Therapeutics Inc. (XRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
110.25M
5-year avg
70.40M
10-year avg
40.44M
XORTX Therapeutics Inc.’s Enterprise Value is less than Context Therapeutics Inc. (1.69M), less than NeuroSense Therapeutics Ltd. (29.28M), less than Better Therapeutics, Inc. (7.71M), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), less than Ensysce Biosciences, Inc. (9.26M),
Company | Enterprise Value | Market cap |
---|---|---|
1.69M | $86.25M | |
29.28M | $29.60M | |
7.71M | $5.45K | |
-667131.00 | $2.45M | |
9.26M | $13.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XORTX Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XORTX Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is XORTX Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for XORTX Therapeutics Inc. (XRTX)?
What is the 3-year average Enterprise Value for XORTX Therapeutics Inc. (XRTX)?
What is the 5-year average Enterprise Value for XORTX Therapeutics Inc. (XRTX)?
How does the current Enterprise Value for XORTX Therapeutics Inc. (XRTX) compare to its historical average?